help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on December 20, 2007, doi:10.1165/rcmb.2007-0255OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2007-0255OCv1
38/5/579    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shvedova, A. A.
Right arrow Articles by Kagan, V. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shvedova, A. A.
Right arrow Articles by Kagan, V. E.
American Journal of Respiratory Cell and Molecular Biology. Vol. 38, pp. 579-590, 2008
© 2008 American Thoracic Society
DOI: 10.1165/rcmb.2007-0255OC

Sequential Exposure to Carbon Nanotubes and Bacteria Enhances Pulmonary Inflammation and Infectivity

Anna A. Shvedova1, James P. Fabisiak2, Elena R. Kisin1, Ashley R. Murray1, Jenny R. Roberts1, Yulia Y. Tyurina2, James M. Antonini1, Wei Hong Feng2, Choudari Kommineni1, Jeffrey Reynolds1, Aaron Barchowsky2, Vince Castranova1 and Valerian E. Kagan2

1 Pathology/Physiology Research Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia; and 2 Departments of Environmental and Occupational Health and Pharmacology, Center for Free Radical and Antioxidant Health, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania

Correspondence and requests for reprints should be addressed to Anna A. Shvedova, Ph.D., NIOSH, PPRB, 1095 Willowdale Rd., Morgantown, WV 26505. E-mail: ats1{at}cdc.gov

Carbon nanotubes (CNT), with their applications in industry and medicine, may lead to new risks to human health. CNT induce a robust pulmonary inflammation and oxidative stress in rodents. Realistic exposures to CNT may occur in conjunction with other pathogenic impacts (microbial infections) and trigger enhanced responses. We evaluated interactions between pharyngeal aspiration of single-walled CNT (SWCNT) and bacterial pulmonary infection of C57BL/6 mice with Listeria monocytogenes (LM). Mice were given SWCNT (0, 10, and 40 µg/mouse) and 3 days later were exposed to LM (103 bacteria/mouse). Sequential exposure to SWCNT/LM amplified lung inflammation and collagen formation. Despite this robust inflammatory response, SWCNT pre-exposure significantly decreased the pulmonary clearance of LM-exposed mice measured 3 to 7 days after microbial infection versus PBS/LM-treated mice. Decreased bacterial clearance in SWCNT-pre-exposed mice was associated with decreased phagocytosis of bacteria by macrophages and a decrease in nitric oxide production by these phagocytes. Pre-incubation of naïve alveolar macrophages with SWCNT in vitro also resulted in decreased nitric oxide generation and suppressed phagocytizing activity toward LM. Failure of SWCNT-exposed mice to clear LM led to a continued elevation in nearly all major chemokines and acute phase cytokines into the later course of infection. In SWCNT/LM-exposed mice, bronchoalveolar lavage neutrophils, alveolar macrophages, and lymphocytes, as well as lactate dehydrogenase level, were increased compared with mice exposed to SWCNT or LM alone. In conclusion, enhanced acute inflammation and pulmonary injury with delayed bacterial clearance after SWCNT exposure may lead to increased susceptibility to lung infection in exposed populations.

Key Words: nanoparticles • infection • inflammation • lung disease • pulmonary injury


CLINICAL RELEVANCE

Exposure to carbon nanotubes and infection induces unusual responses in which both mutually enhance inflammation and depress bacterial clearance. Nanotubes may increase susceptibility to lung infection in exposed populations.

 



This article has been cited by other articles:


Home page
International Journal of ToxicologyHome page
E. Stoker, F. Purser, S. Kwon, Y.-B. Park, and J. S. Lee
Alternative Estimation of Human Exposure of Single-Walled Carbon Nanotubes Using Three-Dimensional Tissue-Engineered Human Lung
International Journal of Toxicology, November 1, 2008; 27(6): 441 - 448.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. A. Shvedova, E. Kisin, A. R. Murray, V. J. Johnson, O. Gorelik, S. Arepalli, A. F. Hubbs, R. R. Mercer, P. Keohavong, N. Sussman, et al.
Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis
Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L552 - L565.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. W. Card, D. C. Zeldin, J. C. Bonner, and E. R. Nestmann
Pulmonary applications and toxicity of engineered nanoparticles
Am J Physiol Lung Cell Mol Physiol, September 1, 2008; 295(3): L400 - L411.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C.-X. Xu, D. Jere, H. Jin, S.-H. Chang, Y.-S. Chung, J.-Y. Shin, J.-E. Kim, S.-J. Park, Y.-H. Lee, C.-H. Chae, et al.
Poly(ester amine)-mediated, Aerosol-delivered Akt1 Small Interfering RNA Suppresses Lung Tumorigenesis
Am. J. Respir. Crit. Care Med., July 1, 2008; 178(1): 60 - 73.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2008 American Thoracic Society.
  Red In Translatin